Today: 8 June 2026
Palantir stock price jumps as AI stocks swing — Nvidia slips ahead of AMD earnings

Palantir stock price jumps as AI stocks swing — Nvidia slips ahead of AMD earnings

NEW YORK, February 3, 2026, 10:13 ET — Regular session

  • Palantir climbs in early trading, fueling interest in AI stocks
  • Shares tied to AI hardware jump after new company announcements
  • After Nvidia’s slide, traders gear up for AMD’s earnings release post-close

By around 10 a.m. ET, Palantir’s shares had climbed 5.1% to $155.30, fueling momentum in AI stocks on Tuesday.

Wall Street started the week riding the AI wave again, building on Monday’s rally in chip stocks that lifted the S&P 500 by 0.54%. “The fundamentals are good and earnings are strong,” said Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder. Big tech names like Alphabet and Amazon are set to report earnings this week. Reuters

Here’s the crux: investors have poured money into anything connected to AI, but it’s earnings that put that hype to the test. What really counts now is guidance, not just beating estimates.

Palantir reported a 66% jump in quarterly U.S. government revenue, reaching $570 million and pushing total sales to $1.41 billion. The company projects 2026 revenue between $7.18 billion and $7.20 billion. CEO Alex Karp emphasized the platform’s “granular permissioning,” ensuring the government “can see only what ought to be seen.” Still, eToro analyst Zavier Wong noted that “valuation question marks won’t disappear” for a stock trading at roughly 140 times next year’s expected earnings — a forward P/E based on these forecasts. Reuters

Teradyne climbed 7.5% following a more than 20% jump in after-hours trading Monday, buoyed by a forecast for first-quarter revenue and profit that topped estimates thanks to AI-driven demand. CEO Greg Smith highlighted expected growth across all business segments in 2026, citing “strong momentum in compute driven by AI.” Reuters

Western Digital rose 1.4% following an announcement that it’s boosting its share repurchase plan by $4 billion. The company linked the buyback to strong demand for memory chips powering AI servers, citing tight supply that’s driven up prices and stretched lead times.

AI giants showed varied moves: Nvidia dipped 1.9%, AMD was down 0.6%, Microsoft slipped 2.0%, yet Alphabet inched higher by 0.5%. C3.ai declined 2.2%.

Europe threw up a red flag. RELX and Wolters Kluwer dropped over 10% after traders flagged Anthropic’s new legal plug-in for its Claude chatbot, stirring fresh skepticism about incumbents holding onto their business models. “The software companies were assumed to be winners from AI,” said Lars Skovgaard, senior investment strategist at Danske Bank. Reuters

Elon Musk revealed that SpaceX has snapped up his AI startup xAI, valuing the companies at $1 trillion and $250 billion, respectively. PitchBook analyst Ali Javaheri noted that Starlink was already generating strong cash flow and “now it adds an AI revenue layer” as SpaceX gears up for a potential IPO. Reuters

Government-linked tech firms are facing heightened scrutiny. Capgemini announced plans to sell a U.S. subsidiary following backlash over a contract with U.S. Immigration and Customs Enforcement. “You don’t need to have that kind of spotlight on you right now,” said Robert Pavlik, senior portfolio manager at Dakota Wealth. Reuters

AMD is set to release its fiscal fourth-quarter and full-year results after the bell, followed by a conference call at 5:00 p.m. EST. Investors will be focused on guidance for data-center chips and looking for signs that AI demand might be easing.

Stock Market Today

  • Indian Stock Market July 8: Cautious Start Amid Middle East Tensions
    June 8, 2026, 9:21 AM EDT. Indian stocks are poised for a cautious open on June 8, impacted by rising Middle East tensions and a global market selloff. The GIFT Nifty index fell over 1%, as Asian markets including South Korea and Japan declined sharply, signaling increased investor risk aversion. Higher crude oil prices and a rebound in gold indicate a shift towards defensive assets. Investors will watch key domestic developments in companies like TVS Motor, RailTel, KNR Constructions, Creative Newtech, Amber Enterprises, and Ixigo. Fundraising activities at Zee, ASM Technologies, and Gujarat Themis, along with regulatory issues at Yes Bank, 5Paisa, and Reliance Infrastructure, will also remain in focus.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Constellation Software’s 48% slide has investors split as AI fears rattle software stocks
Previous Story

Constellation Software’s 48% slide has investors split as AI fears rattle software stocks

SCHD dividend ETF is beating the S&P 500 in 2026 — what’s driving the comeback
Next Story

SCHD dividend ETF is beating the S&P 500 in 2026 — what’s driving the comeback

Go toTop